Shire Pharmaceuticals, PA
(Specialty Pharmaceutical)
- Vice President of Regulatory Affairs
- Senior Director of Regulatory Affairs
- Global Director of Regulatory Operations
- Associate Director of Regulatory Affairs
Shire Pharmaceuticals, PA
(Specialty Pharmaceutical)
Shire Pharmaceuticals develops and markets specialty drug products for use in the treatment of central nervous system (CNS), gastrointestinal (GI) and renal diseases. One of its leading products is Adderall XR, which is used in the treatment of attention-deficit hyperactivity disorder (ADHD). Shire currently generates 70 percent of its more than $1 billion in annual revenues in the United States.